Uranium Royalty (UROY) Competitors $1.84 +0.03 (+1.66%) Closing price 04:00 PM EasternExtended Trading$1.83 -0.01 (-0.54%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock UROY vs. CSR, AAMI, SBR, PGRE, NXRT, GETY, ABL, AC, TINV, and AACTShould you be buying Uranium Royalty stock or one of its competitors? The main competitors of Uranium Royalty include Centerspace (CSR), Acadian Asset Management (AAMI), Sabine Royalty Trust (SBR), Paramount Group (PGRE), NexPoint Residential Trust (NXRT), Getty Images (GETY), Abacus Life (ABL), Associated Capital Group (AC), Tiga Acquisition (TINV), and Ares Acquisition Co. II (AACT). These companies are all part of the "trading" industry. Uranium Royalty vs. Centerspace Acadian Asset Management Sabine Royalty Trust Paramount Group NexPoint Residential Trust Getty Images Abacus Life Associated Capital Group Tiga Acquisition Ares Acquisition Co. II Uranium Royalty (NASDAQ:UROY) and Centerspace (NYSE:CSR) are both small-cap energy companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, community ranking, risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings. Does the media favor UROY or CSR? In the previous week, Centerspace had 3 more articles in the media than Uranium Royalty. MarketBeat recorded 6 mentions for Centerspace and 3 mentions for Uranium Royalty. Centerspace's average media sentiment score of 1.75 beat Uranium Royalty's score of 0.45 indicating that Centerspace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Uranium Royalty 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Centerspace 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do insiders & institutionals believe in UROY or CSR? 24.2% of Uranium Royalty shares are held by institutional investors. Comparatively, 79.0% of Centerspace shares are held by institutional investors. 0.4% of Centerspace shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more risk and volatility, UROY or CSR? Uranium Royalty has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500. Comparatively, Centerspace has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500. Do analysts recommend UROY or CSR? Uranium Royalty presently has a consensus target price of $4.00, indicating a potential upside of 120.39%. Centerspace has a consensus target price of $71.70, indicating a potential upside of 19.47%. Given Uranium Royalty's stronger consensus rating and higher probable upside, analysts clearly believe Uranium Royalty is more favorable than Centerspace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Uranium Royalty 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00Centerspace 0 Sell rating(s) 5 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the MarketBeat Community believe in UROY or CSR? Centerspace received 16 more outperform votes than Uranium Royalty when rated by MarketBeat users. However, 90.91% of users gave Uranium Royalty an outperform vote while only 43.90% of users gave Centerspace an outperform vote. CompanyUnderperformOutperformUranium RoyaltyOutperform Votes2090.91% Underperform Votes29.09%CenterspaceOutperform Votes3643.90% Underperform Votes4656.10% Is UROY or CSR more profitable? Uranium Royalty has a net margin of 0.00% compared to Centerspace's net margin of -4.34%. Uranium Royalty's return on equity of 1.79% beat Centerspace's return on equity.Company Net Margins Return on Equity Return on Assets Uranium RoyaltyN/A 1.79% 1.75% Centerspace -4.34%-1.34%-0.60% Which has preferable earnings & valuation, UROY or CSR? Centerspace has higher revenue and earnings than Uranium Royalty. Centerspace is trading at a lower price-to-earnings ratio than Uranium Royalty, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUranium Royalty$23.14M10.48$7.24M$0.0360.50Centerspace$260.98M3.85$41.97M-$1.27-47.26 SummaryUranium Royalty beats Centerspace on 11 of the 19 factors compared between the two stocks. Get Uranium Royalty News Delivered to You Automatically Sign up to receive the latest news and ratings for UROY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UROY vs. The Competition Export to ExcelMetricUranium RoyaltyCommodity contracts brokers, dealers IndustryEnergy SectorNASDAQ ExchangeMarket Cap$242.55M$22.67B$7.01B$7.94BDividend YieldN/A5.28%10.94%4.23%P/E Ratio60.5217.5946.7318.55Price / Sales10.4810.4825,023.18103.00Price / Cash37.5321.5935.4434.62Price / Book1.071.163.494.26Net Income$7.24M$1.63B$4.30B$248.39M7 Day Performance-2.94%-2.99%-0.83%1.27%1 Month Performance-0.82%-2.04%-5.90%3.85%1 Year Performance-22.44%6.60%162.15%5.23% Uranium Royalty Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UROYUranium Royalty1.301 of 5 stars$1.84+1.7%$4.00+117.4%-21.0%$245.89M$23.14M61.3510CSRCenterspace3.8901 of 5 stars$60.23+1.2%$71.70+19.0%-10.4%$1.01B$260.98M-47.43470Earnings ReportPositive NewsAAMIAcadian Asset Management1.9383 of 5 stars$26.95+0.1%$25.33-6.0%N/A$998.93M$505.60M12.03350Earnings ReportNews CoverageSBRSabine Royalty Trust1.687 of 5 stars$67.37+0.4%N/A+7.0%$982.19M$82.57M10.382,020Upcoming EarningsShort Interest ↑PGREParamount Group2.6797 of 5 stars$4.39flat$4.08-7.0%-7.6%$962.40M$757.45M-4.48330Short Interest ↑NXRTNexPoint Residential Trust4.3236 of 5 stars$36.62+0.4%$46.33+26.5%+9.1%$935.06M$259.70M20.933Earnings ReportDividend AnnouncementShort Interest ↑News CoveragePositive NewsGap UpGETYGetty Images2.8931 of 5 stars$2.00+2.0%$4.60+130.0%-48.2%$825.14M$939.29M16.671,700Short Interest ↑ABLAbacus Life3.4755 of 5 stars$8.24-0.4%$14.00+69.9%-29.6%$798.07M$111.92M-45.7882Upcoming EarningsAnalyst ForecastNews CoveragePositive NewsACAssociated Capital Group2.7778 of 5 stars$34.91+0.0%N/A+10.3%$738.42M$13.18M16.8620Upcoming EarningsShort Interest ↓TINVTiga AcquisitionN/A$21.07+1.2%N/A+121.3%$726.92MN/A0.00N/AGap DownHigh Trading VolumeAACTAres Acquisition Co. IIN/A$11.260.0%N/A+6.0%$703.44MN/A0.00N/AUpcoming EarningsHigh Trading Volume Related Companies and Tools Related Companies Centerspace Competitors Acadian Asset Management Competitors Sabine Royalty Trust Competitors Paramount Group Competitors NexPoint Residential Trust Competitors Getty Images Competitors Abacus Life Competitors Associated Capital Group Competitors Tiga Acquisition Competitors Ares Acquisition Co. II Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UROY) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored"I'm risking my reputation on this"I've stayed quiet for too long, but after everything I've uncovered about what's brewing in the 2025 crypto ma...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Uranium Royalty Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Uranium Royalty With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.